Vertex Pharmaceuticals (VRTX) EBIT (QoQ) (2009 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.62% |
| Dec 31, 2025 | 1.66% |
| Sep 30, 2025 | 3.05% |
| Jun 30, 2025 | 82.69% |
| Mar 31, 2025 | -38.59% |
| Dec 31, 2024 | -8.09% |
| Sep 30, 2024 | 131.76% |
| Jun 30, 2024 | -408.44% |
| Mar 31, 2024 | 15.28% |
| Dec 31, 2023 | -4.78% |
| Sep 30, 2023 | 1.14% |
| Jun 30, 2023 | 31.76% |
| Mar 31, 2023 | -24.63% |
| Dec 31, 2022 | -8.27% |
| Sep 30, 2022 | 1.84% |
| Jun 30, 2022 | 6.28% |
| Mar 31, 2022 | 18.59% |
| Dec 31, 2021 | -16.77% |
| Sep 30, 2021 | 2,882.32% |
| Jun 30, 2021 | -104.27% |
| Mar 31, 2021 | 19.04% |
| Dec 31, 2020 | 10.94% |
| Sep 30, 2020 | -6.38% |
| Jun 30, 2020 | -0.30% |
| Mar 31, 2020 | 30.60% |
| Dec 31, 2019 | 455.17% |
| Sep 30, 2019 | -63.20% |
| Jun 30, 2019 | -2.47% |
| Mar 31, 2019 | 116.73% |
| Dec 31, 2018 | -37.89% |
| Sep 30, 2018 | 18.96% |
| Jun 30, 2018 | 34.12% |
| Mar 31, 2018 | 2.52% |
| Dec 31, 2017 | 138.56% |
| Sep 30, 2017 | -718.60% |
| Jun 30, 2017 | -80.54% |
| Mar 31, 2017 | 583.25% |
| Dec 31, 2016 | 311.67% |
| Sep 30, 2016 | -658.51% |
| Jun 30, 2016 | 123.40% |
| Mar 31, 2016 | 73.32% |
| Dec 31, 2015 | 23.31% |
| Sep 30, 2015 | 59.09% |
| Jun 30, 2015 | 0.48% |
| Mar 31, 2015 | -11.95% |
| Dec 31, 2014 | -8.03% |
| Sep 30, 2014 | 21.24% |
| Jun 30, 2014 | 16.43% |
| Mar 31, 2014 | -2,001.37% |
| Dec 31, 2013 | 91.68% |
| Sep 30, 2013 | -162.71% |
| Jun 30, 2013 | 89.04% |
| Mar 31, 2013 | -453.90% |
| Dec 31, 2012 | -7,133.99% |
| Sep 30, 2012 | 90.06% |
| Jun 30, 2012 | -111.75% |
| Mar 31, 2012 | -59.07% |
| Dec 31, 2011 | 3.80% |
| Mar 31, 2011 | 4.04% |
| Dec 31, 2010 | 16.51% |
| Sep 30, 2010 | -17.70% |
| Jun 30, 2010 | -5.80% |
| Mar 31, 2010 | -9.24% |
| Dec 31, 2009 | 1.02% |
| Sep 30, 2009 | 5.68% |
| Jun 30, 2009 | 2.92% |